✦ LIBER ✦

Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers

✍ Scribed by J.C. Soria; C. Massard; N. Magné; Th. Bader; C.D. Mansfield; J.Y. Blay; B.N. Bui; A. Moussy; O. Hermine; J.P. Armand

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I, first-in-human dose-escalatio

✍ Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 232 KB

36 ORAL A Phase I single dose escalation

✍ P. Schöffski; A. Awada; H. Dumez; T. Gil; S. Bartholomeus; J. Selleslach; M. Tat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Phase I dose escalation and pharmacokine

✍ Toru Mukohara; Shunji Nagai; Minori Koshiji; Kenichi Yoshizawa; Hironobu Minami 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Phase I–IIa study of BMS-690514, an EGFR

✍ Soria, Jean-Charles; Baselga, José; Hanna, Nasser; Laurie, Scott A.; Bahleda, Ra 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 343 KB

396 A Phase I, Dose-finding Study of BI

✍ de Jonge, M.; Sahebjam, S.; Mathijssen, R.H.; Razak, A.; van der Biessen, D.; Pr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Phase I dose escalation study of MK-0457

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB